Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 3
1947 1
1948 12
1949 2
1950 3
1951 4
1952 2
1953 2
1956 3
1957 7
1958 5
1959 6
1960 1
1961 4
1962 3
1963 1
1964 3
1965 3
1966 1
1967 3
1968 6
1969 3
1970 4
1971 2
1972 1
1973 1
1974 3
1975 1
1976 2
1977 5
1978 1
1979 6
1980 3
1981 5
1982 8
1983 3
1984 2
1985 5
1986 2
1987 4
1988 4
1989 2
1990 4
1991 3
1992 7
1993 6
1994 3
1995 5
1996 9
1997 8
1998 6
1999 8
2000 8
2001 11
2002 11
2003 8
2004 14
2005 21
2006 25
2007 25
2008 22
2009 37
2010 30
2011 33
2012 27
2013 28
2014 47
2015 66
2016 56
2017 43
2018 52
2019 61
2020 94
2021 110
2022 77
2023 75
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

1,076 results

Results by year

Filters applied: . Clear all
Page 1
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Holmes J, Howitt BE, Lea J, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Aggarwal S. Abu-Rustum N, et al. J Natl Compr Canc Netw. 2023 Feb;21(2):181-209. doi: 10.6004/jnccn.2023.0006. J Natl Compr Canc Netw. 2023. PMID: 36791750
Adenocarcinoma of the endometrium (also known as endometrial cancer, or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. It is estimated that 65,950 new uterine …
Adenocarcinoma of the endometrium (also known as endometrial cancer, or more broadly as uterine cancer or carcinoma of the ute …
Use of Straighteners and Other Hair Products and Incident Uterine Cancer.
Chang CJ, O'Brien KM, Keil AP, Gaston SA, Jackson CL, Sandler DP, White AJ. Chang CJ, et al. J Natl Cancer Inst. 2022 Dec 8;114(12):1636-1645. doi: 10.1093/jnci/djac165. J Natl Cancer Inst. 2022. PMID: 36245087 Free PMC article.
RESULTS: Over an average of 10.9 years of follow-up, 378 uterine cancer cases were identified. Ever vs never use of straightening products in the previous 12 months was associated with higher incident uterine cancer rates (HR = 1.80, 95% CI = 1.12 to 2 …
RESULTS: Over an average of 10.9 years of follow-up, 378 uterine cancer cases were identified. Ever vs never use of straighten …
Gynecologic Malignancies.
Suneja G, Viswanathan A. Suneja G, et al. Hematol Oncol Clin North Am. 2020 Feb;34(1):71-89. doi: 10.1016/j.hoc.2019.08.018. Hematol Oncol Clin North Am. 2020. PMID: 31739953 Review.
Disparities in Gynecologic Cancers.
Lee NK, Tiro JA, Odunsi K. Lee NK, et al. Cancer J. 2023 Nov-Dec 01;29(6):343-353. doi: 10.1097/PPO.0000000000000678. Cancer J. 2023. PMID: 37963369 Review.
Our review documents the persistent racial and ethnic disparities in cervical, ovarian, and uterine cancer outcomes, with Black patients experiencing the worst outcomes, and notes literature investigating social determinants of health, particularly access to care. A …
Our review documents the persistent racial and ethnic disparities in cervical, ovarian, and uterine cancer outcomes, with Blac …
Bleeding from Gynecologic Malignancies.
Hutchcraft ML, Miller RW. Hutchcraft ML, et al. Obstet Gynecol Clin North Am. 2022 Sep;49(3):607-622. doi: 10.1016/j.ogc.2022.02.022. Obstet Gynecol Clin North Am. 2022. PMID: 36122988 Review.
Choice of treatment is disease site specific. Cervical cancer frequently is treated with chemoradiation. Uterine cancer may be treated surgically, with radiation, or pharmacologically. ...
Choice of treatment is disease site specific. Cervical cancer frequently is treated with chemoradiation. Uterine cancer may be …
Lynch syndrome.
Backes FJ, Cohn DE. Backes FJ, et al. Clin Obstet Gynecol. 2011 Jun;54(2):199-214. doi: 10.1097/GRF.0b013e3182185a41. Clin Obstet Gynecol. 2011. PMID: 21508689 Review.
Initially, the syndrome was named Hereditary Nonpolyposis Colorectal Cancer as colorectal cancer seemed most prevalent. Over time uterine cancer and several other malignancies were recognized as part of the spectrum. This autosomal-dominant inherited cancer syndrome …
Initially, the syndrome was named Hereditary Nonpolyposis Colorectal Cancer as colorectal cancer seemed most prevalent. Over time uterine …
Atypical polypoid adenomyoma.
Grindstaff S, Banet N. Grindstaff S, et al. Int J Gynecol Cancer. 2021 Apr;31(4):639-640. doi: 10.1136/ijgc-2020-001886. Int J Gynecol Cancer. 2021. PMID: 33795408 No abstract available.
What next in cervical cancer screening?
Sehnal B, Sláma J. Sehnal B, et al. Ceska Gynekol. 2020 Winter;85(4):236-243. Ceska Gynekol. 2020. PMID: 33562978 Review. English.
Prevention of breast cancer.
Olver IN. Olver IN. Med J Aust. 2016 Nov 21;205(10):475-479. doi: 10.5694/mja16.01007. Med J Aust. 2016. PMID: 27852187 Review.
Uncommon but serious side effects include thromboembolism and uterine cancer. Raloxifene, which can also reduce osteoporosis, can be used in post-menopausal women and is not associated with the development of uterine cancer. ...
Uncommon but serious side effects include thromboembolism and uterine cancer. Raloxifene, which can also reduce osteoporosis, …
1,076 results